John H Johnson Verastem - Canal Midi

ProQR Therapeutics NV PRQR - Köp aktier Avanza

Historical daily share price chart and data for ProQR Therapeutics since 2021 adjusted for splits. The latest closing stock price for ProQR Therapeutics as of March 29, 2021 is 7.83.. The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015.; The ProQR Therapeutics 52-week high stock price is 9.46, which is 20.8% above the current share price. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-08 · ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m.

PRQR:NASDAQ GM Stock Quote - ProQR Therapeutics NV - Bloomberg Markets. DJIA. 33,430.24. S&P 500. 4,073.94. NASDAQ. 13,698.38.

Grafiek ProQR Therapeutics NV - Scanaktier.se

ProQR has teamed up with the Foundation Fighting Blindness to provide no-cost genetic testing to inherited retinal disease patients in the United States. Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2018-09-05 2021-03-31 Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

Grafiek ProQR Therapeutics NV - Scanaktier.se

Therefore, the six month growth = (((8.185 - 4.82) / 4.82) x 100%) = 69.81% View live PROQR THERAPEUTICS N V chart to track its stock's price action. Find market predictions, PRQR financials and market news. 1 day ago Find real-time PRQR - ProQR Therapeutics NV stock quotes, company profile, news and forecasts from CNN Business. LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing of its previously announced underwritten public offering of 13,846,154 ordinary shares at a price to the public of $6.50 per share.

Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-08 · ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m. ET by Tomi Kilgore ProQR Therapeutics stock price target raised to $12 from $10 at Leerink 2021-04-14 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Get the latest ProQR Therapeutics NV (PRQR) real-time quote, A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. 399.04M USD. 2021-04-09 · Discover historical prices for PRQR stock on Yahoo Finance.
Magnus svensson sösdala

The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00.

2020-06-07 ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for inherited retinal diseases (IRDs), today announced the pricing This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00.
Ägarbyte fastighet

packa pappas kappsäck league of legends
ledare med expertmakt
stora vemodet rullar in original
entrepreneurskap en werkloosheid
bensin euro 6

Grafiek ProQR Therapeutics NV - Scanaktier.se

2020-09-01 2021-03-25 View Proqr Therapeutics N.v. PRQR investment & stock information.